Burrage Capital Management is an investment fund managing more than $99.7 million ran by Jeff Crispen. There are currently 22 companies in Mr. Crispen’s portfolio. The largest investments include Biocryst Pharmaceuticals and Intellia Therapeutics Inc, together worth $24 million.
$99.7 million Assets Under Management (AUM)
As of 9th August 2021, Burrage Capital Management’s top holding is 864,916 shares of Biocryst Pharmaceuticals currently worth over $13.7 million and making up 13.7% of the portfolio value.Relative to the number of outstanding shares of Biocryst Pharmaceuticals, Burrage Capital Management owns more than approximately 0.1% of the company.In addition, the fund holds 63,634 shares of Intellia Therapeutics Inc worth $10.3 million, whose value grew 128.0% in the past six months. The third-largest holding is Epizyme Inc worth $6.95 million and the next is Essa Pharma Inc worth $6.78 million, with 237,442 shares owned.
Currently, Burrage Capital Management's portfolio is worth at least $99.7 million. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Burrage Capital Management
The Burrage Capital Management office and employees reside in Boston, Massachusetts. According to the last 13-F report filed with the SEC, Jeff Crispen serves as the Chief Financial Officer at Burrage Capital Management.
